Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of Radiotherapy (RAPPER)

NCT00601406 is registered in ClinicalTrials.gov with The Christie NHS Foundation Trust as lead sponsor.

NCT NCT00601406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00601406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of Radiotherapy (RAPPER)
Lead sponsor
The Christie NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2006
Completion date
Not reported
Enrollment
2,200 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cervical cancer, endometrial cancer, fallopian tube cancer, ovarian cancer, primary peritoneal cavity cancer, prostate cancer, sarcoma, vaginal cancer, vulvar cancer